Unknown

Dataset Information

0

P62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.


ABSTRACT: p62/IMP2 is an oncofetal protein that is overexpressed in several types of cancer, and is a member of the family of insulin-like growth factor 2 mRNA binding proteins. We previously reported that high levels of p62/IMP2 autoantibody are present in sera from cancer patients, compared to healthy individuals. Here, we report the overexpression of p62/IMP2 in tumor tissues of 72 out of 104 cases of human breast cancer, and high levels of p62/IMP2 autoantibody in patients' sera (in 63 out of 216 cases). To explore the role of p62/IMP2 in breast cancer progression, we generated p62/IMP2 transfected variants of two human breast cancer cell lines: MDA-MB-231 and LM2-4. Using in vitro assays we found that overexpression of p62/IMP2 can increase cell migration, and reduce cell adhesion to extracellular matrix (ECM) proteins. A Human Extracellular Matrix and Adhesion Molecules qPCR array was performed with our generated variants, and it identified a group of mRNAs whose expression was altered with p62/IMP2 overexpression, including connective tissue growth factor (CTGF) mRNA - which we show to be a p62/IMP2 binding partner. Overall, our results provide new insights into the molecular mechanism by which p62/IMP2 can contribute to breast cancer progression.

SUBMITTER: Li Y 

PROVIDER: S-EPMC4741720 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.

Li Yang Y   Francia Giulio G   Zhang Jian-Ying JY  

Oncotarget 20151001 32


p62/IMP2 is an oncofetal protein that is overexpressed in several types of cancer, and is a member of the family of insulin-like growth factor 2 mRNA binding proteins. We previously reported that high levels of p62/IMP2 autoantibody are present in sera from cancer patients, compared to healthy individuals. Here, we report the overexpression of p62/IMP2 in tumor tissues of 72 out of 104 cases of human breast cancer, and high levels of p62/IMP2 autoantibody in patients' sera (in 63 out of 216 case  ...[more]

Similar Datasets

| S-EPMC7017416 | biostudies-literature
| S-EPMC10470750 | biostudies-literature
| S-EPMC6222013 | biostudies-literature
| S-EPMC4632283 | biostudies-literature
| S-EPMC2949640 | biostudies-literature
| S-EPMC3117883 | biostudies-literature
2022-03-31 | PXD029518 | Pride
| S-EPMC3076137 | biostudies-literature
| S-EPMC3978930 | biostudies-literature
| S-EPMC7584814 | biostudies-literature